Skip to content
MS
PW-025 Nucleotide Metabolism Anabolic (salvage) unreviewed

Purine Salvage Pathway

Free purine bases (hypoxanthine, guanine, adenine) + PRPP IMP, GMP, AMP
Compartment
Cytosol
Main tissue
Brain, RBC, most tissues
Rate-limiting
Not flagged in the source
Steps
8

Reaction steps

In source order, 8 total

showing 1–8
  1. 1

    Hypoxanthine → IMP

    Out IMP
    Notes

    HGPRT catalyzes hypoxanthine + PRPP → IMP + PPi. Mg2+ supports phosphoribosyl transfer, and PPi hydrolysis drives the reaction forward. This is effectively irreversible in vivo and salvages hypoxanthine directly to the central purine intermediate.

  2. 2

    Guanine → GMP

    In Guanine
    Out GMP
    Notes

    HGPRT catalyzes guanine + PRPP → GMP + PPi. This is also effectively irreversible in vivo; the same enzyme therefore salvages both hypoxanthine and guanine.

  3. 3

    Adenine → AMP

    In Adenine
    Out AMP
    Notes

    Adenine phosphoribosyltransferase (APRT) catalyzes adenine + PRPP → AMP + PPi. The reaction uses PRPP and Mg2+ and is effectively irreversible because cellular pyrophosphatases hydrolyze PPi.

  4. 4

    Adenosine → AMP

    Adenosine kinase 2.7.1.20 ST-0209 Irreversible/directional ATP
    Out AMP
    Notes

    Adenosine kinase catalyzes adenosine + ATP → AMP + ADP. This ATP-dependent route is important for recycling adenosine and for terminating extracellular/intracellular adenosine signaling after uptake; it is not a PRPP-dependent reaction.

  5. 5

    Inosine → hypoxanthine + ribose 1-phosphate

    Notes

    Purine nucleoside phosphorylase (PNP) catalyzes inosine + Pi ⇌ hypoxanthine + ribose 1-phosphate. Although this reaction is reversible and is often viewed as degradative, the liberated hypoxanthine can immediately enter the HGPRT reaction in an operational salvage sequence.

  6. 6

    Guanosine → guanine + ribose 1-phosphate

    Purine nucleoside phosphorylase (PNP) 2.4.2.1 ST-0211 Irreversible/directional Pi
    Notes

    PNP catalyzes guanosine + Pi ⇌ guanine + ribose 1-phosphate. Guanine can then be salvaged by HGPRT; direction in vivo depends on substrate and phosphate concentrations.

  7. 7

    Deoxyadenosine → deoxyadenosine monophosphate (dAMP)

    Notes

    Deoxycytidine kinase (dCK) and, in selected tissues, deoxyguanosine kinase (dGK) can phosphorylate deoxyadenosine using ATP: deoxyadenosine + ATP → dAMP + ADP. These nucleoside kinases are especially relevant to deoxynucleoside salvage and activation of nucleoside analog drugs; dGK is mitochondrial, whereas dCK is cytosolic/nuclear.

  8. 8

    Deoxyguanosine → deoxyguanosine monophosphate (dGMP)

    Notes

    dCK (and mitochondrial dGK where expressed) catalyzes deoxyguanosine + ATP → dGMP + ADP. Subsequent nucleoside monophosphate and diphosphate kinases generate dGDP and dGTP.

Showing all 8 steps.

Regulation

What speeds each enzyme up and what slows it down

PRPP synthetase

Accelerated by

Inorganic phosphate; ribose 5-phosphate availability

Inhibited by

ADP, GDP, purine nucleotide feedback

Hormonal

Indirectly increased by insulin-supported carbohydrate metabolism; no defining direct hormonal allostery.

HGPRT

Accelerated by

Availability of hypoxanthine/guanine and PRPP

Inhibited by

Product inhibition by IMP/GMP; low PRPP limits flux

Hormonal

No important acute hormonal regulation; constitutive activity is critical in neural tissue.

APRT

Accelerated by

Adenine and PRPP availability

Inhibited by

AMP and low PRPP

Hormonal

No established direct hormonal control.

Adenosine kinase

Accelerated by

Adenosine availability

Inhibited by

High AMP/ADP burden and product effects; limited by ATP availability

Hormonal

Expression varies with tissue state; no canonical endocrine allosteric regulator.

Overview

Purine salvage conserves preformed purine bases and nucleosides by reconverting them into nucleotides, thereby avoiding the high energetic cost of de novo synthesis. It is particularly important in tissues with high purine turnover or limited de novo synthesis, including brain, bone marrow, and erythrocytes. Salvage also limits conversion of purine bases to uric acid and helps regulate PRPP availability.

Cellular location

The principal phosphoribosyltransferase reactions occur in the cytosol of virtually all cells. Hypoxanthine-guanine phosphoribosyltransferase (HGPRT/HPRT) activity is especially physiologically important in the central nervous system, where reliance on salvage is high; adenosine kinase is abundant in many tissues, including liver, brain, and endothelium. Nucleoside transporters at the plasma membrane and intracellular membranes supply bases/nucleosides to the cytosolic enzymes.

Net energetics

PRPP-dependent salvage of adenine, hypoxanthine, or guanine consumes the activated ribose donor PRPP, whose synthesis costs ATP → AMP, i.e., two high-energy phosphate equivalents; the transfer reaction itself does not consume another ATP. Salvage therefore avoids the six ATP-equivalent cost and multiple atom donors required to build IMP de novo. Adenosine or deoxynucleoside kinase routes consume one ATP → ADP per nucleoside monophosphate formed, followed by additional kinase reactions if triphosphates are required.

Clinical significance

Salvage restrains purine overproduction by consuming PRPP and generating IMP, AMP, and GMP, which feedback-inhibit de novo synthesis. Near-complete HGPRT deficiency causes Lesch-Nyhan syndrome, characterized by hyperuricemia, dystonia/choreoathetosis, developmental impairment, and self-injurious behavior; partial deficiency causes Kelley-Seegmiller syndrome with gout/urolithiasis but less severe neurologic disease. APRT deficiency causes 2,8-dihydroxyadenine nephrolithiasis, a preventable cause of crystalline kidney disease. PNP deficiency impairs T-cell function, whereas defects of deoxynucleoside kinases affect mitochondrial DNA maintenance and alter nucleoside-analog drug responses.

Recent literature

Live Europe PMC search

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Multi-omics dissection of metabolic hijacking: Infectious bronchitis virus orchestrates lipid-centric replication through PPAR-TGF-β crosstalk.

    Yan K, Wang X, Bo Z, Zhang C, Guo M, Zhang X, Wu Y. · 2026-01-28

    cited 1× open access unreviewed
  2. 2
    Alpha-ketoglutarate accelerates granulocyte-monocyte progenitor differentiation and atherosclerotic plaque inflammation via oxoglutarate receptor 1.

    Zhao J, Su L, Li W, Lam SM, Yan C, Zhou T, Deng Y, Dong Y, Zhou Y, Shui G, Feng Y. · 2026-03-27

    cited 1× open access unreviewed
  3. 3
    Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-like Pancreatic Cancer.

    Pan CH, Lyu Y, Ghosh M, Siraj MA, Tseng R, Chaika NV, Haley JD, Khalvatifahlylani B, Tuveson DA, Patel HD, Fa… · 2026-06-01

    cited 1× open access unreviewed
  4. 4
    Rationale for the Use of 8-Aminoguanine for the Management of Cystitis.

    Birder LA, Stern JNH, Moldwin R, Jackson EK. · 2026-05-01

    open access unreviewed
  5. 5
  6. 6
    p1/s1, a 3'-nucleotidase/nuclease, allows Leishmania major to circumvent host innate immune response mechanisms.

    Schmelzle SM, Bergmann M, Walber B, Shamsara J, Ziesmann T, Distler U, Miskey C, Childs L, Kolb P, Tenzer S, … · 2026-05-20

    open access unreviewed
  7. 7
    Gut microbial-host isozymes: A novel perspective on gut microbiota-host interactions.

    Liu X, Wen C, Gu S, Hao Y, Xiong Y, Chen C, Zeng S, Zhang P. · 2026-03-04

    open access unreviewed
  8. 8
    Meat quality and metabolism alterations in broiler driven by selective breeding and their associations with gut microbiota.

    Xu L, Cai Z, Li Z, Chen L, Zeng T, Li R, Xu W, Gu T, Lu L. · 2026-04-24

    open access unreviewed
  9. 9
    Purine metabolic adaptation protects the endothelium from disturbed flow-induced DNA damage and atherosclerosis.

    Ma Q, Cai Y, Zhang Z, Zhao D, Zhao Y, Xu P, Lu T, Zhang W, Yang Q, Zhou Y, Sudhahar V, Fukai T, Jo H, Xu Y, H… · 2026-04-30

    open access unreviewed
  10. 10
    Purine salvage pathway protects CD8<sup>+</sup> T cells from metabolic stress.

    Tajima M, Hao H, Zhang B, Matsuoka Y, Sonomura K, Imami K, Isobe Y, Maeda R, Lin YH, Shimba A, Kato R, Costa … · 2026-04-13

    cited 1× unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.